BioOutsource and Cellca are now Sartorius Stedim Biotech

We are proud to announce BioOutsource and Cellca are now Sartorius Stedim Biotech providing a fully integrated cell line and upstream development service.

Sartorius Stedim Biotech, a leading supplier of products and services for the biopharmaceutical industry, acquired BioOutsource and Cellca to further expand their portfolio of innovative drug development services.

BioOutsource and Cellca provide a fully integrated portfolio of services to provide a total solution for biopharmaceutical drug development; BioOutsource are global leaders in contract testing & research services, and Cellca a leading provider of cell line development & upstream process. The joint business offering provides a total solution to support drug development, from early stage cell line development, GMP cell bank manufacture & characterization, analytical testing from clone selection, process development, characterization through to GMP lot release. Committed to offering a first class service package, Sartorius Stedim Biotech are consistently developing technology with their in-house R&D departments to expand their extensive technical expertise to address market demands.

Learn more about our expertise and service offering.

Learn more

Sartorius Stedim Biotech – Upstream Development Services Locations

Glasgow, UK – BioOutsource Contract Testing Services & Cell Bank Manufacture

Laupheim, Germany – Cellca Cell Line Development & Upstream Process

Cambridge, USA  – North America Bioanalytical and Biosafety Testing Services

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy